Average Co-Inventor Count = 5.17
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Targacept, Inc. (32 from 91 patents)
2. Other (4 from 832,718 patents)
3. Oyster Point Pharma, Inc. (4 from 18 patents)
4. Catalyst Biosciences, Inc. (2 from 26 patents)
5. Targaeept, Inc. (1 from 1 patent)
43 patents:
1. 11542253 - Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine
2. 10919879 - Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine
3. 10716770 - Nicotinic receptor non-competitive antagonists
4. 10421745 - Salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine
5. 10258582 - Nicotinic receptor non-competitive antagonists
6. 9981949 - Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine
7. 9532974 - Nicotinic receptor non-competitive antagonists
8. 9145396 - Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3ylvinyl)pyrimidine
9. 8809397 - Nicotinic receptor non-competitive antagonists
10. 8802694 - 3,6-diazabicyclo[3.1.1]heptanes as neuronal nicotinic acetycholine receptor ligands
11. 8604191 - Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3YLVINYL)pyrimidine
12. 8288420 - Compounds capable of activating cholinergic receptors
13. 8153821 - Compounds
14. 7923559 - N-aryl diazaspirocyclic compounds and methods of preparation and use thereof
15. 7897611 - Pharmaceutical compositions and methods for relieving pain and treating central nervous system disorders